Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects

被引:305
|
作者
Borghi, R
Marchese, R
Negro, A
Marinelli, L
Forloni, G
Zaccheo, D
Abbruzzese, G
Tabaton, M
机构
[1] Univ Genoa, Dept Expt Med, Inst Human Anat, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Neurosci, I-16132 Genoa, Italy
[3] Univ Padua, Dept Biol Chem, I-35100 Padua, Italy
[4] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
关键词
alpha-synuclein; Parkinson's disease; cerebrospinal fluid; neurodegenerative diseases; biological markers;
D O I
10.1016/S0304-3940(00)01153-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Several clues suggest that alpha-synuclein, a presynaptic protein, plays a central role in the pathogenesis of idiopathic Parkinson's disease (PD). To search a peripheral marker of PD, we analyzed presence and amount of alpha-synuclein in CSF from 12 PD patients and 10 neurologically normal subjects. The protein was extracted from CSF samples through immunoprecipitation and immunoblotting with different specific anti-alpha-synuclein antibodies. We identified a 19 kDa band that corresponds to monomeric alpha-synuclein, given its comigration with homologue human recombinant peptide as well as with the protein extracted from cerebral cortex of normal subjects. The amount of CSF 19 kDa alpha-synuclein did not significantly vary in PD and normal cases. These findings have two implications: (a) full length alpha-synuclein is released by neurons in the extracellular space; (b) alpha-synuclein does not appear a peripheral marker of PD pathology. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:65 / 67
页数:3
相关论文
共 50 条
  • [1] Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
    Tokuda, Takahiko
    Salem, Sultan A.
    Allsop, David
    Mizuno, Toshiki
    Nakagawa, Masanori
    Qureshi, Mohamed M.
    Locascio, Joseph J.
    Schlossmacher, Michael G.
    El-Agnaf, Omar M. A.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 349 (01) : 162 - 166
  • [2] Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease
    Forland, Marthe Gurine
    Ohrfelt, Annika
    Dalen, Ingvild
    Tysnes, Ole-Bjorn
    Blennow, Kaj
    Zetterberg, Henrik
    Pedersen, Kenn Freddy
    Alves, Guido
    Lange, Johannes
    [J]. PARKINSONISM & RELATED DISORDERS, 2018, 49 : 4 - 8
  • [3] The native form of α-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls
    Jakowec, MW
    Petzinger, GM
    Sastry, S
    Donaldson, DM
    McCormack, A
    Langston, JW
    [J]. NEUROSCIENCE LETTERS, 1998, 253 (01) : 13 - 16
  • [4] Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease
    Balducci, Chiara
    Pierguidi, Laura
    Persichetti, Emanuele
    Parnetti, Lucilla
    Sbaragli, Michele
    Tassi, Carmelo
    Orlacchio, Aldo
    Calabresi, Paolo
    Beccari, Tommaso
    Rossi, Aroldo
    [J]. MOVEMENT DISORDERS, 2007, 22 (10) : 1481 - 1484
  • [5] Cerebrospinal fluid α-synuclein levels in Parkinson's disease - changed or unchanged?
    Zetterberg, H.
    Petzold, M.
    Magdalinou, N.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (03) : 365 - 367
  • [6] Altered Cerebrospinal Fluid Levels of α-Synuclein and Aβ in Parkinson Disease
    Kotzbauer, Paul T.
    Buddhala, Chandana
    Campbell, Meghan C.
    Perlmutter, Joel S.
    [J]. ANNALS OF NEUROLOGY, 2013, 74 : S42 - S42
  • [7] Diagnostic biomarkers for Parkinson's disease: focus on a-synuclein in cerebrospinal fluid
    Kalia, Lorraine V.
    [J]. PARKINSONISM & RELATED DISORDERS, 2019, 59 : 21 - 25
  • [8] Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
    Parnetti, Lucilla
    Chiasserini, Davide
    Persichetti, Emanuele
    Eusebi, Paolo
    Varghese, Shiji
    Qureshi, Mohammad M.
    Dardis, Andrea
    Deganuto, Marta
    De Carlo, Claudia
    Castrioto, Anna
    Balducci, Chiara
    Paciotti, Silvia
    Tambasco, Nicola
    Bembi, Bruno
    Bonanni, Laura
    Onofrj, Marco
    Rossi, Aroldo
    Beccari, Tommaso
    El-Agnaf, Omar
    Calabresi, Paolo
    [J]. MOVEMENT DISORDERS, 2014, 29 (08) : 1019 - 1027
  • [9] Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease
    Mollenhauer, Brit
    Caspell-Garcia, Chelsea J.
    Coffey, Christopher S.
    Taylor, Peggy
    Singleton, Andy
    Shaw, Leslie M.
    Trojanowski, John Q.
    Frasier, Mark
    Simuni, Tanya
    Iranzo, Alex
    Oertel, Wolfgang
    Siderowf, Andrew
    Weintraub, Daniel
    Seibyl, John
    Toga, Arthur W.
    Tanner, Caroline M.
    Kieburtz, Karl
    Chahine, Lana M.
    Marek, Kenneth
    Galasko, Douglas
    Jennings, Danna
    Lasch, Shirley
    Siderowf, Andrew
    Tanner, Caroline
    Simuni, Tatyana
    Coffey, Chris
    Kieburtz, Karl
    Flagg, Emily
    Chowdhury, Sohini
    Poewe, Werner
    Mollenhauer, Brit
    Sherer, Todd
    Frasier, Mark
    Meunier, Claire
    Rudolph, Alice
    Casaceli, Cindy
    Seibyl, John
    Mendick, Susan
    Schuff, Norbert
    Zhang, Ying
    Toga, Arthur
    Ansbach, Alison
    De Blasio, Pas-quale
    Piovella, Michele
    Trojanowski, John
    Shaw, Leslie M.
    Singleton, Andrew
    Hawkins, Keith
    Eberling, Jamie
    Russell, David
    [J]. MOVEMENT DISORDERS, 2019, 34 (09) : 1354 - 1364
  • [10] Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
    Parnetti, Lucilla
    Chiasserini, Davide
    Bellomo, Gianni
    Giannandrea, David
    De Carlo, Claudia
    Qureshi, Mohamed M.
    Ardah, Mustafa T.
    Varghese, Shiji
    Bonanni, Laura
    Borroni, Barbara
    Tambasco, Nicola
    Eusebi, Paolo
    Rossi, Aroldo
    Onofrj, Marco
    Padovani, Alessandro
    Calabresi, Paolo
    El-Agnaf, Omar
    [J]. MOVEMENT DISORDERS, 2011, 26 (08) : 1428 - 1435